WMSA
INSY

Weiss Multi-Strategy Advisers’s Insys Therapeutics, Inc. INSY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,000
Closed -$133K – 706
2017
Q3 		$133K Buy
+15,000
New +$155K ﹤0.01% 464

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Weiss Multi-Strategy Advisers's INSY Position: Q1 2019 in Review

Weiss Multi-Strategy Advisers sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 35,000 shares — an estimated $123K sold.

Weiss Multi-Strategy Advisers first reported a position in INSY in Q2 2014 and held it in 19 quarters. The position peaked at $2.62M in Q1 2015. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • Weiss Multi-Strategy Advisers reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 35,000 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $123K.
  • Weiss Multi-Strategy Advisers first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 19 quarters.
  • Weiss Multi-Strategy Advisers's Insys Therapeutics, Inc. position peaked at $2.62M in Q1 2015.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.